These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 2322987)
1. Triple combination of retinoic acid plus actinomycin D plus dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture. Hassan HT; Rees J Cancer Chemother Pharmacol; 1990; 26(1):26-30. PubMed ID: 2322987 [TBL] [Abstract][Full Text] [Related]
2. Triple combination of retinoic acid, low concentration of cytarabine and dimethylformamide induces differentiation of human acute myeloid leukaemic blasts. Hassan HT; Rees JK Chemotherapy; 1990; 36(1):51-7. PubMed ID: 2307025 [TBL] [Abstract][Full Text] [Related]
3. Triple combination of retinoic acid+aclacinomycin A+ dimethylformamide induces differentiation of human acute myeloid leukaemic blasts in primary culture. Hassan HT; Rees JK Anticancer Res; 1989; 9(3):647-51. PubMed ID: 2764511 [TBL] [Abstract][Full Text] [Related]
4. Triple combination of retinoic acid + 6-thioguanine + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture. Tawhid H; Rees J Leuk Res; 1990; 14(2):109-17. PubMed ID: 2314112 [TBL] [Abstract][Full Text] [Related]
5. Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human AML blasts in primary culture. Hassan HT; Rees JK Hematol Oncol; 1989; 7(6):429-40. PubMed ID: 2807181 [TBL] [Abstract][Full Text] [Related]
6. Retinoic acid alone and in combination with cytosine arabinoside induces differentiation of human myelomonocytic and monoblastic leukaemic cells. Hassan HT; Rees JK Hematol Oncol; 1988; 6(1):39-45. PubMed ID: 3422632 [TBL] [Abstract][Full Text] [Related]
7. New synergistic combinations of differentiation inducing agents in the treatment of acute myeloid leukaemia. Hassan HT; Zyada LE; Ragab MH; Rees JK Eur J Clin Pharmacol; 1991; 41(6):531-6. PubMed ID: 1815964 [TBL] [Abstract][Full Text] [Related]
8. Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays. Hassan HT; Veit A; Maurer HR J Cancer Res Clin Oncol; 1991; 117(3):227-31. PubMed ID: 1709642 [TBL] [Abstract][Full Text] [Related]
9. Screening for induction of differentiation and toxicity to blast cells by chemotherapeutic compounds in human myeloid leukemia. Lotem J; Berrebi A; Sachs L Leuk Res; 1985; 9(2):249-58. PubMed ID: 3857410 [TBL] [Abstract][Full Text] [Related]
10. A phase-1 study of dasatinib plus all-trans retinoic acid in acute myeloid leukemia. Redner RL; Beumer JH; Kropf P; Agha M; Boyiadzis M; Dorritie K; Farah R; Hou JZ; Im A; Lim SH; Raptis A; Sehgal A; Christner SM; Normolle D; Johnson DE Leuk Lymphoma; 2018 Nov; 59(11):2595-2601. PubMed ID: 29616864 [TBL] [Abstract][Full Text] [Related]
11. Combinations of retinoic acid with either sodium butyrate, dimethyl sulfoxide, or hexamethylene bisacetamide synergistically induce differentiation of the human myeloid leukemia cell line HL60. Breitman TR; He RY Cancer Res; 1990 Oct; 50(19):6268-73. PubMed ID: 2400989 [TBL] [Abstract][Full Text] [Related]
12. Recombinant human interleukin-6 enhances the antiproliferation and differentiation inducing effects of retinoic acid in HL-60 human myeloid leukaemic cells. Hassan HT Clin Exp Pharmacol Physiol; 1991 Dec; 18(12):847-51. PubMed ID: 1797449 [TBL] [Abstract][Full Text] [Related]
13. Differentiation induction in myelodysplasia and acute myeloid leukaemia: use of synergistic drug combinations. Francis GE; Mufti GJ; Knowles SM; Berney JJ; Guimaraes JE; Secker-Walker LM; Hamblin TJ Leuk Res; 1987; 11(11):971-7. PubMed ID: 3480401 [TBL] [Abstract][Full Text] [Related]
14. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Breitman TR; Selonick SE; Collins SJ Proc Natl Acad Sci U S A; 1980 May; 77(5):2936-40. PubMed ID: 6930676 [TBL] [Abstract][Full Text] [Related]
16. Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia. Kuendgen A; Knipp S; Fox F; Strupp C; Hildebrandt B; Steidl C; Germing U; Haas R; Gattermann N Ann Hematol; 2005 Dec; 84 Suppl 1():61-6. PubMed ID: 16270213 [TBL] [Abstract][Full Text] [Related]
17. The differentiating effect of retinoic acid and vincristine on acute myeloid leukemia. Leung MF; Wong KF J Hematother; 1999 Jun; 8(3):275-9. PubMed ID: 10417051 [TBL] [Abstract][Full Text] [Related]
18. Epigallocatechin-3-gallate induces cell death in acute myeloid leukaemia cells and supports all-trans retinoic acid-induced neutrophil differentiation via death-associated protein kinase 2. Britschgi A; Simon HU; Tobler A; Fey MF; Tschan MP Br J Haematol; 2010 Apr; 149(1):55-64. PubMed ID: 20096012 [TBL] [Abstract][Full Text] [Related]
19. Potentiation between intracellular cyclic-AMP-elevating agents and inducers of leukemic cell differentiation. Fontana J; Munoz M; Durham J Leuk Res; 1985; 9(9):1127-32. PubMed ID: 2415782 [TBL] [Abstract][Full Text] [Related]
20. Comparison of the antiproliferative effects of transforming growth factor-beta, N,N-dimethylformamide and retinoic acid on a human colon carcinoma cell line. Hoosein NM; Brattain DE; McKnight MK; Childress KE; Chakrabarty S; Brattain MG Cancer Lett; 1988 Jun; 40(2):219-32. PubMed ID: 3164250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]